Renaissance Technologies’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-605,132
| Closed | -$51.4M | – | 4018 |
|
|
2019
Q4 | $51.4M | Sell |
605,132
-419,600
| -41% | -$28M | 0.04% | 513 |
|
|
2019
Q3 | $51.2M | Buy |
1,024,732
+671,300
| +190% | +$26.8M | 0.04% | 496 |
|
|
2019
Q2 | $12.9M | Buy |
+353,432
| New | +$11.5M | 0.01% | 1233 |
|
|
2017
Q4 | – | Sell |
-129,029
| Closed | -$4.78M | – | 3582 |
|
|
2017
Q3 | $4.78M | Sell |
129,029
-199,803
| -61% | -$7.37M | 0.01% | 1801 |
|
|
2017
Q2 | $12.5M | Buy |
328,832
+166,500
| +103% | +$7.42M | 0.02% | 1122 |
|
|
2017
Q1 | $7.94M | Sell |
162,332
-253,568
| -61% | -$11.6M | 0.01% | 1397 |
|
|
2016
Q4 | $14.1M | Buy |
415,900
+407,800
| +5,035% | +$14.5M | 0.02% | 1010 |
|
|
2016
Q3 | $306K | Buy |
+8,100
| New | +$305K | ﹤0.01% | 2955 |
|
|
2016
Q2 | – | Sell |
-287,361
| Closed | -$9.13M | – | 3605 |
|
|
2016
Q1 | $9.13M | Buy |
287,361
+38,329
| +15% | +$1.25M | 0.02% | 1207 |
|
|
2015
Q4 | $9.3M | Buy |
249,032
+152,600
| +158% | +$5.77M | 0.02% | 1038 |
|
|
2015
Q3 | $3.66M | Buy |
+96,432
| New | +$3.39M | 0.01% | 1595 |
|
|
2014
Q2 | – | Sell |
-53,042
| Closed | -$1.51M | – | 3070 |
|
|
2014
Q1 | $1.51M | Buy |
+53,042
| New | +$1.76M | ﹤0.01% | 1898 |
|
Other funds holding MDCO
Renaissance Technologies's MDCO Position: Q1 2020 in Review
Renaissance Technologies sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 605,132 shares — an estimated $51.4M sold.
Renaissance Technologies first reported a position in MDCO in Q1 2014 and held it in 12 quarters. The position peaked at $51.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Renaissance Technologies reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Renaissance Technologies sold 605,132 Medicines Co shares in Q1 2020, an estimated $51.4M.
- Renaissance Technologies first reported a position in Medicines Co in Q1 2014 and held it in 12 quarters.
- Renaissance Technologies's Medicines Co position peaked at $51.4M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.